Articles From: Hillshire Brands to buy Pinnacle Foods for $4.3 billion to Bridgepoint Education Reports Preliminary First Quarter 2014 Results

By Ben Fox Rubin By Ben Fox Rubin Hillshire Brands Co.
Sign-up for Hillshire Brands to buy Pinnacle Foods for $4.3 billion investment picks
BALTIMORE , May 12, 2014 /PRNewswire/ -- Legg Mason , Inc. (NYSE: LM) reported preliminary assets under management of $673 billion as of April 30 , 2014.
Sign-up for Legg Mason Reports Assets Under Management For April 2014 investment picks
Recommends Stockholders Vote Revised White Proxy Card PHILADELPHIA , May 12, 2014 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: ECTE) , a medical device company developing its Symphony ® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it has filed its definitive proxy materials with the Securities and Exchange Commission in connection with its 2014 Annual Meeting of Stockholders to be held on Thursday, June 19, 2014 , at 10:00 a.m. EDT , at Echo's offices located at 10 Forge Parkway, Franklin, Massachusetts 02038.
Sign-up for Echo Therapeutics Files Definitive Proxy Materials investment picks
Note: All figures are quoted in U.S. dollars unless otherwise noted.
Sign-up for Ivanhoe Energy Reports First Quarter 2014 Financial Results investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that William Lis, chief executive officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on Thursday, May 15, 2014, at 10:00 a.m. Pacific Time.
Sign-up for Portola Pharmaceuticals to Present at Bank of America Merrill Lynch 2014 Health Care Conference investment picks SMART kapp, dry-erase board replacement, launches at InfoComm, June 18-20 CALGARY, AB --
Sign-up for SMART Revolutionizes the Dry Erase Board With SMART kapp (TM) investment picks
NEW YORK (MarketWatch) -- The U.S. Food and Drug Administration has approved a new drug by Merck (MRK) that lowers the risk of heart attacks and cardiovascular events associated with peripheral arterial disease.
Sign-up for FDA approves Merck's heart-attack prevention drug investment picks
By Quentin Fottrell 1.
Sign-up for UPDATE: 10 things CEOs won't tell you investment picks
-Quentin Fottrell; 415-439-6400; 7.
Sign-up for UPDATE: 10 things CEOs won't tell you -2- investment picks
2014/5/12 TASER's HQ in Scottsdale, AZ.
Sign-up for TASER International Authorizes Stock Buy-Back Program for up to $30 Million of Company Stock investment picks
BLAINE, Wash., May 12, 2014 (GLOBE NEWSWIRE) -- Mobetize Corp.
Sign-up for Mobetize Corp. to Participate in International Telecoms Week 2014 investment picks
QUÉBEC CITY, May 12, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announces that following its annual meeting of shareholders held on May 9, 2014 , its Board of Directors has appointed current President and CEO, David Dodd , as Chairman of the Board, a decision that is in keeping with Aeterna Zentaris' new strategy of transitioning from a research and development into a commercial company.
Sign-up for Aeterna Zentaris Announces Board of Directors Leadership Change and Election of Directors at Annual Meeting of Shareholders investment picks LYON, FRANCE --
Sign-up for Flamel Technologies Announces First Quarter of Fiscal Year 2014 Results investment picks
Provides Guidance of Revenue and Net Income for the Fourth Quarter of Fiscal Year 2014, and Updates Guidance of Revenue and Net Income for Fiscal Year 2014 XI'AN, China, May 12, 2014 /PRNewswire-FirstCall/ -- Third Quarter of FY 2014 net sales increased 6.7% to $70.3 million; net income decreased 46.2% to $7.2million with EPS of $0.23. The Company Provided Fourth Quarter of Fiscal Year 2014 Guidance Range: Revenue, Net Income and EPS of between $60 million and $70 million , $6 million and $7 million , and $0.19 and $ 0.22 based on 31.8 million numbers of fully diluted shares, respectively.
Sign-up for China Green Agriculture, Inc. Reports the Financial Results for the Third Quarter of Fiscal Year 2014 investment picks
Product is being developed to treat pain in dogs with osteoarthritis KANSAS CITY, Kan.
Sign-up for Aratana Therapeutics Initiates Pivotal Study for AT-001 investment picks
Sign-up for Ceres Awarded Patent for Innovation in Corn investment picks
- Revenue Increased 236.5% Year-Over-Year to 152.3 Million - - Generated Net Income of $23.6 Million Compared to a Net Loss of $0.6 Million a Year Ago - BEIJING , May 12, 2014 /PRNewswire-FirstCall/ -- Yongye International, Inc. (NASDAQ: YONG) ("Yongye" or the "Company"), a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), today announced its financial results for the quarter ended March 31, 2014 .
Sign-up for Yongye International Announces First Quarter 2014 Financial Results investment picks Figure 1 - Cross Section 1+62.5 North Figure 2 - Plan Map Figure 3 - Cross Section 3+25 South VANCOUVER, BC--(Marketwired - May 12, 2014) - Balmoral Resources Ltd.
Sign-up for Balmoral Intersects 1,138 g/t (33 oz/ton) Gold Over 4.87 Metres, Bug Lake Footwall Zone, Detour Gold Trend Project, Quebec investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch) -- Can M&A save this stock market?
Sign-up for UPDATE: Tech, small-cap stock slide may give way to M&A rush investment picks
NEW YORK (MarketWatch) -- Botox-maker Allergan Inc (AGN) said its board has unanimously rejected the unsolicited bid from Valeant Pharmaceuticals International Inc (VRX), which it said "substantially" undervalues the company.
Sign-up for Allergan board unanimously rejects Valeant bid investment picks
By Hester Plumridge LONDON --
Sign-up for Pfizer details AstraZeneca bid for U.K. lawmakers investment picks
2014/5/12 NORTH PALM BEACH, FL --
Sign-up for Attitude Drinks and King Supplements Partner to Promote Phase III(R) Recovery Online investment picks
2014/5/12 NEW YORK, NY--(Marketwired - May 12, 2014) - El Maniel International, Inc. (PINKSHEETS: EMLL) is pleased to announce that the Company's insider plans to retire up to two billion shares of its common stock within a 12 months period so as to facilitate merger and acquisition transactions and make our stock more appealing to prospective acquisition targets.
Sign-up for El Maniel International Inc. Announces Plans to Retire up to 20% of Outstanding Shares of Insider investment picks
HOUSTON, May 12, 2014 (GLOBE NEWSWIRE) -- Energy XXI Gulf Coast, Inc. (the "Company"), the operating subsidiary of Energy XXI (Bermuda) Limited ("Energy XXI") (Nasdaq:EXXI) (AIM:EXXI), today announced that it intends, subject to market and other conditions, to offer up to $300 million aggregate principal amount of its senior unsecured notes due 2024 (the "2024 Notes") in a private placement to eligible purchasers (the "Offering"). The Company intends to use a portion of the net proceeds to repay all indebtedness outstanding under its revolving credit facility and the remainder to fund a portion of the cash consideration for Energy XXI's pending acquisition of EPL Oil & Gas, Inc. (the "EPL Acquisition"). If the EPL Acquisition is not consummated, the Company intends to use all of the remaining net proceeds for general corporate purposes.
Sign-up for Energy XXI Gulf Coast, Inc. Announces $300 Million Offering of Senior Notes investment picks
Online feature makes ordering for large groups fast and easy ANN ARBOR, Mich.
Sign-up for Domino's Pizza® Launches New Online Group Ordering Tool investment picks MINNEAPOLIS, MN --
Sign-up for ValueVision Mails Letter to Shareholders investment picks
SAN DIEGO, May 12, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) , a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the initiation of a Phase 2b clinical trial of its lead drug candidate, emricasan, in post-orthotopic liver transplant (POLT) recipients with reestablished liver fibrosis post-transplant as a result of recurrent hepatitis C virus (HCV) infection who have successfully achieved a sustained viral response (SVR) following HCV antiviral therapy (POLT-HCV-SVR). The placebo-controlled, double-blind (open to sponsor) trial is designed to enroll approximately 60 patients at approximately 15 planned U.S. clinical sites.
Sign-up for Conatus Pharmaceuticals Initiates Phase 2b Trial Targeting Fibrosis in Liver Transplant Recipients investment picks
May 13 webinar presents solutions for enterprises looking to optimize cost-performance and accelerate time-to-value with HP Vertica BURLINGTON, Massachusetts , May 12, 2014 /PRNewswire/ -- Attunity Ltd.
Sign-up for Attunity Hosts Live Webinar on Enabling a Modern Technology Platform for Big Data Analytics investment picks
On Wednesday, May 21, 2014, Xcel Energy (NYSE: XEL) will hold its annual shareholders meeting in Fargo, ND, at 11:00 a.m. Central Time.
Sign-up for Xcel Energy to Webcast Annual Shareholders Meeting investment picks
SAN DIEGO , May 12, 2014 /PRNewswire/ -- Bridgepoint Education (NYSE: BPI) , a provider of postsecondary education services, announced its preliminary results for the first quarter ended March 31, 2014.
Sign-up for Bridgepoint Education Reports Preliminary First Quarter 2014 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Hillshire Brands to buy Pinnacle Foods for $4.3 billion to Bridgepoint Education Reports Preliminary First Quarter 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry